Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Evaluation of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Asmaa Atteya, MD, Aiman Ahmad, MD, Dima Daghstani, BSC, Mohamed A Yassin, MBBS, MSc

Blood (2019) 134 (Supplement_1): 1648.

https://doi.org/10.1182/blood-2019-121834

Published: 2019

Journal Articles

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

Wei Liu, Rui Lv, Wenyang Huang, Hong Liu, Shuhui Deng, MD, Shuhua Yi, MD, Lulu Lv, Jianxiang Wang, MD, Lugui Qiu, MD PhD, Dehui Zou, MD

Blood (2019) 134 (Supplement_1): 2913.

https://doi.org/10.1182/blood-2019-126635

Published: 2019

Journal Articles

An Analysis from the WM UK Rory Morrison Registry: Waldenström's Macroglobulinaemia Patient Demographics, Disease Characteristics and Evolving Treatment Choices

Oliver Tomkins, BMBS, MRCP, Joshua Bomsztyk, Helen McCarthy, MBBS, PhD, Jaimal Kothari, Dima El-Sharkawi, Charalampia Kyriakou, Guy Pratt, Ali Rismani, MBBS, Shirley D'Sa

Blood (2019) 134 (Supplement_1): 4016.

https://doi.org/10.1182/blood-2019-129212

Published: 2019

Journal Articles

The Effect of Hepatitis B Virus Antibody on Clinical Outcome and Prognosis in Patients with Diffuse Large B-Cell Lymphoma

Shunfeng Hu, Na Chen, MD, Kang Lu, MD PhD, Changqing Zhen, MD PhD, Yi Zhao, MM, Xin Wang, MD PhD

Blood (2019) 134 (Supplement_1): 4134.

https://doi.org/10.1182/blood-2019-127870

Published: 2019

Journal Articles

The Real-Life Data on the Outcome of Hepatitis B Infection in Patients with B-Cell Lymphoproliferative Neoplasms Treated with Ibrutinib

Abdulkadir Ercaliskan, MD, Ahmet Emre Eskazan, MD, Nurgul Ozgur Yurttas, MD, Selin Kucukyurt, MD, Ayse Salihoglu, MD, Dilek Keskin, MD, Deniz Ozmen, MD, Tugrul Elverdi, MD, Muhlis Cem Ar, MD PhD, Teoman Soysal, MD

Blood (2019) 134 (Supplement_1): 4316.

https://doi.org/10.1182/blood-2019-127794

Published: 2019

Journal Articles

Study of Seroprevalence of Hepatites "B" and "C" Markers in Blood Donors from Hemonorte, Rio Grande Do Norte/ Brazil

Ralfo Cavalcanti Medeiros, Manuel Josué Batista Neto, Aldair Sousa Paiva, PhDMD, Valéria SF Sales, PhD, Rodrigo Villar Freitas, MD, Hugo Diogenes De Oliveira Paiva, MD, Rafael Santiago Araujo, Geraldo Barroso Cavalcanti, Jr., PhD

Blood (2019) 134 (Supplement_1): 4992.

https://doi.org/10.1182/blood-2019-127188

Published: 2019

Journal Articles

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy

Shigeru Kusumoto, Luca Arcaini, Xiaonan Hong, Jie Jin, Won Seog Kim, Yok Lam Kwong, Marion G. Peters, Yasuhito Tanaka, Andrew D. Zelenetz, Hiroshi Kuriki, Günter Fingerle-Rowson, Tina Nielsen, Eisuke Ueda, Hanna Piper-Lepoutre, Gila Sellam, Kensei Tobinai

Blood (2019) 133 (2): 137–146.

https://doi.org/10.1182/blood-2018-04-848044

Published: 2019

Includes: Supplemental data

Journal Articles

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Blood (2018) 132 (Supplement 1): 4209.

https://doi.org/10.1182/blood-2018-99-114850

Published: 2018

Journal Articles

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

Hua Yin, Suli Wang, Xingyu Lu, Wenyi Shen, MD, Ruinan Lu, Yu Zhu, MD PhD, Kourong Miao, Ming Hong, MD PhD, Shuai Wang, MD PhD, Jianfu Zhang, Chun Qiao, Yujie Wu, Xuemei Wu, Guangsheng He, Jianyong Li, MD PhD

Blood (2018) 132 (Supplement 1): 5107.

https://doi.org/10.1182/blood-2018-99-118836

Published: 2018

Journal Articles

Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy

Ian J Hooley, BS, Robert Chen, PhD, Kathleen Maignan, NP, Kenneth R. Carson, MD PhD

Blood (2018) 132 (Supplement 1): 2249.

https://doi.org/10.1182/blood-2018-99-113636

Published: 2018

Journal Articles

Hepatitis B Virus (HBV) Screening and Associated Outcomes in Malignant Hematology Patients Receiving Rituximab Therapy within the Rossy Cancer Network

Shen Li, MD, Allaa Ali, MPH, Alexander Lawandi, MD BS, BA, MSc, Myriam Fernandez, RN, Caroline Rousseau, PhD, Doneal Thomas, M.Phil, M.Sc, Sarit Assouline, Chantal Cassis, MD, Todd Campbell Lee, MD MPH, Kelly L. Davison, MD PhD

Blood (2018) 132 (Supplement 1): 2256.

https://doi.org/10.1182/blood-2018-99-119079

Published: 2018

Journal Articles

Managing the Risk of Hepatitis B Virus Reactivation in Patients with B-Cell Lymphomas Treated with Obinutuzumab or Rituximab Immunochemotherapy

Shigeru Kusumoto, MD, Luca Arcaini, MD, Xiaonan Hong, Jie Jin, Won Seog Kim, MD, Ph. D., Yok Lam Kwong, Marion Peters, Yasuhito Tanaka, Andrew D. Zelenetz, MD PhD, Hiroshi Kuriki, Günter Fingerle-Rowson, Tina Nielsen, Eisuke Ueda, Hanna Piper-Lepoutre, Gila Sellam, Kensei Tobinai, MD PhD

Blood (2017) 130 (Supplement 1): 2823.

https://doi.org/10.1182/blood.V130.Suppl_1.2823.2823

Published: 2017

Journal Articles

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

Nurgul Ozgur Yurttas, MD, Burak Sarilar, MD, Ahmet Emre Eskazan, MD, Deniz Ozmen, MD, Dilek Keskin, MD, Sevil Sadri, MD, Selin Berk, MD, Ayse Salihoglu, MD, M. Cem Ar, MD PhD, Seniz Ongoren, MD, Zafer Baslar, MD, Yildiz Aydin, MD, Teoman Soysal, MD

Blood (2017) 130 (Supplement 1): 2888.

https://doi.org/10.1182/blood.V130.Suppl_1.2888.2888

Published: 2017

Journal Articles

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Blood (2017) 130 (Supplement 1): 5213.

https://doi.org/10.1182/blood.V130.Suppl_1.5213.5213

Published: 2017

Journal Articles

Low Risk for Viral Reactivation during Induction for Acute Myeloid Leukemia in Hepatitis B Silent Carriers Who Are Negativefor Hepatitis B Surface Antigen

Tsofia Inbar, MD, Shehrban Sobeh Khalil, MD, Ron Ram, MD, Chezi Ganzel, MD, Yishai Ofran, MD

Blood (2017) 130 (Supplement 1): 2172.

https://doi.org/10.1182/blood.V130.Suppl_1.2172.2172

Published: 2017

Journal Articles

HBV Care Map for Patients Receiving Anti-CD20 Therapy

Zachary Liederman, MD, Neil Berinstein, MD, Michael Crump, MD, Jessica Hwang, MD MPH, Harry L.A. Janssen, PhD MD, C. Tom Kouroukis, MDMSc,FRCPC, Patricia Leung, Anna Lok, MD, Colina Yim, Andrew D. Zelenetz, MD PhD, Kelvin Chan, MD PhD, Jordan Feld, MD MPH, Lisa K. Hicks, MD MSc

Blood (2017) 130 (Supplement 1): 4697.

https://doi.org/10.1182/blood.V130.Suppl_1.4697.4697

Published: 2017

Journal Articles

Real Life Data on Clinical Aspects and Treatment of Marginal Zone Lymphoma: An Analysis from the NF10 Project, an International, Prospective, Observational Study of the Fondazione Italiana Linfomi

Blood (2017) 130 (Supplement 1): 1493.

https://doi.org/10.1182/blood.V130.Suppl_1.1493.1493

Published: 2017

Journal Articles

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Muhned Alhumaid, MD, Syed Osman Ali Ahmed, BSc, FRCPath, MBBS, MRCP, Fahad Al Mohareb, MD, Fahad Z. Alsharif, MB,MD, Hazzaa Alzahrani, MD, Naeem A. Chaudhri, MD, Raid El Fakih, MD, Amr Hanbali, MD, Shahrukh K. Hashmi, MDMPH, Said Yousuf Ahmed, MD, Walid Rasheed, MB, CHB, FRACP, FRCPA, Marwan Shaheen, MD, Tusneem Elhassan, MSc, Feras Abdulaziz Alfraih, MD

Blood (2017) 130 (Supplement 1): 5498.

https://doi.org/10.1182/blood.V130.Suppl_1.5498.5498

Published: 2017

Journal Articles

Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy

Blanca Sanchez-Gonzalez, MD PhD, Montserrat Garcia-Retortillo, MD PhD, Teresa Murcia, PhD, Mariana Ferraro, MD, Francesc Garcia-Pallarols, BSc, Dolors Gimenez, Sara Montesdeoca, Eva Gimeno, MD PhD, Eugenia Abella, MD PhD, Ricard Sola, MD PhD, Carlos Besses, MD PhD, Antonio Salar, MD PhD

Blood (2016) 128 (22): 1801.

https://doi.org/10.1182/blood.V128.22.1801.1801

Published: 2016

Journal Articles

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Ohad Benjamini, MD, Maya Zlotnick, MD, Elena Ribakovsky, MD, Meirav Kedmi, MD, Adrian Duek, MD, Drorit Merkel, MD, Merav Leiba, MD, Ivetta Danylesko, MD, Noga Shem-Tov, MD, Ronit Yerushalmi, MD, Avichai Shimoni, MD, Abraham Avigdor, MD, Arnon Nagler, Yulia Volchek, MD

Blood (2016) 128 (22): 5429.

https://doi.org/10.1182/blood.V128.22.5429.5429

Published: 2016

NARROW

Evaluation of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

The Risk of Hepatitis B Reactivation Is Controllable in Patients with Concomitant Hepatitis B Virus Infection during Chimeric Antigen Receptor T-Cell Therapy

An Analysis from the WM UK Rory Morrison Registry: Waldenström's Macroglobulinaemia Patient Demographics, Disease Characteristics and Evolving Treatment Choices

The Effect of Hepatitis B Virus Antibody on Clinical Outcome and Prognosis in Patients with Diffuse Large B-Cell Lymphoma

The Real-Life Data on the Outcome of Hepatitis B Infection in Patients with B-Cell Lymphoproliferative Neoplasms Treated with Ibrutinib

Study of Seroprevalence of Hepatites "B" and "C" Markers in Blood Donors from Hemonorte, Rio Grande Do Norte/ Brazil

Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy

Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy

Reactivation of Hepatitis B Virus Infection in Aplastic Anemia Patients Receiving Immunosuppressive Therapy

Hepatitis B Testing Rates in Patients with Chronic Lymphocytic Leukemia before and during Administration of Anti-CD20 Therapy

Hepatitis B Virus (HBV) Screening and Associated Outcomes in Malignant Hematology Patients Receiving Rituximab Therapy within the Rossy Cancer Network

Managing the Risk of Hepatitis B Virus Reactivation in Patients with B-Cell Lymphomas Treated with Obinutuzumab or Rituximab Immunochemotherapy

Hepatitis B Virus Seropositivity in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitors: Preliminary Results of a Single-Center Cross-Sectional Study

The Incidence of HBV Reactivation in Patients Receiving First-Line R-CHOP Chemotherapy: Three-Year Follow-up Results from a Prospective, Observational Study

Low Risk for Viral Reactivation during Induction for Acute Myeloid Leukemia in Hepatitis B Silent Carriers Who Are Negativefor Hepatitis B Surface Antigen

HBV Care Map for Patients Receiving Anti-CD20 Therapy

Real Life Data on Clinical Aspects and Treatment of Marginal Zone Lymphoma: An Analysis from the NF10 Project, an International, Prospective, Observational Study of the Fondazione Italiana Linfomi

Impact of Anti-Hepatitis B Core Following Allogeneic Bone Marrow Transplantation; Single Center Study of 489 Patients

Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy

Evaluation of the Risk of Hepatitis B Reactivation Among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only